Drexel University has selected Ultrafix, a Drexel-affiliated orthopedic medical device startup, to receive support from its Innovation Fund. The company, founded by Sorin Siegler, PhD, professor emeritus in Drexel’s College of Engineering, will receive an investment of $150,000 from the fund. This is the third such tranche of support offered to Drexel-affiliated startups since the Innovation Fund’s creation in 2023.
Ultrafix is developing a novel class of orthopedic surgical devices, based on controlled expansion bone anchor technology developed in Siegler’s lab over the last decade and a half. Siegler’s goal for the bone anchor products is to reduce revision surgeries and produce better patient outcomes for a variety of orthopedic procedures.
“This support will enable Ultrafix to bring a revolutionary bone anchor technology to populations for which traditional orthopedic products would not be a viable solution,” Siegler said. “These products are based on decades of biomechanical research, testing and development and we believe they will be an important, new tool for orthopedic procedures.”
Siegler’s swelling bone anchor research has received prior support from state and foundation funding, as well as the Drexel Coulter Translational Research Partnership. Siegler was also involved in prior successful commercialization of total ankle replacement technology from Drexel.
Full story: Drexel Selects Orthopedic Surgical Device Startup for Innovation Fund Support
